StockData

VitaSpring Biomedical Co. Ltd. (VSBC) income statement

VSBCOTCServices-Commercial Physical & Biological ResearchFiscal year ends January 31
Số liệu tài chính tới Q2 năm tài chính 2027, quý kết thúc ngày Jul 31, 2026Last filing: 10-Q on Sep 17, 2026Score 4/30
$0.03+0.00 (0.00%)

Close on Oct 19, 2026Market cap $6.58MP/E –Yield –

VitaSpring Biomedical Co. Ltd. income statement

Ratios

Latest available, balances at Jul 31, 2026

Profitability, TTM

Gross margin
–
Operating margin
–
Net margin
–
Return on equity, FY2026
9.8%

Financial strength

Current ratio
0.01
Debt to equity
–
Debt to assets
–
Cash to current liabilities
0.6%

Valuation

P/E ratio
–
Price to sales
–
Price to book
–
Dividend yield
–

See a number that looks wrong?